Humacyte
Mr. Shukla has served as AHAC’s Chairman and Chief Executive Officer since inception and has two decades of buyouts, investments and operations experience in the healthcare industry. He served as Chairman and Chief Executive Officer of CNAC, successfully closing its initial business combination with DermTech. Mr. Shukla holds a Masters in Healthcare Management and Policy from Harvard University and a Bachelors in Pharmaceutics from the Indian Institute of Technology.
This person is not in the org chart
This person is not in any offices
Humacyte
1 followers
Humacyte, Inc., is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine.